dactinomycin has been researched along with 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le, NT; Richardson, DR | 1 |
| Liang, SX; Richardson, DR | 1 |
2 other study(ies) available for dactinomycin and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone
| Article | Year |
|---|---|
Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
Topics: Cell Cycle; Cells, Cultured; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Endopeptidases; Dactinomycin; Deferoxamine; DNA Damage; Gene Expression Regulation; Humans; Iron Chelating Agents; Isoniazid; Multienzyme Complexes; Proteasome Endopeptidase Complex; Protein Biosynthesis; Receptors, Transferrin; RNA, Messenger; Tumor Suppressor Protein p53 | 2003 |
The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1.
Topics: Blotting, Northern; Blotting, Western; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dactinomycin; Electrophoretic Mobility Shift Assay; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Iron Chelating Agents; Isoniazid; Protein Synthesis Inhibitors; RNA, Messenger; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Suppressor Protein p53 | 2003 |